AI assistant
EXACT SCIENCES CORP — Director's Dealing 2014
May 6, 2014
30597_dirs_2014-05-06_cf1bbfb8-f555-4d10-a4d7-433b42ced242.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2014-05-05
Reporting Person: Megan William J. (SVP, Finance & PFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-30 | Common Stock | A | 2522 | $9.32 | Acquired | 2522 | Direct |
| 2014-05-05 | Common Stock | P | 10000 | $11.792 | Acquired | 12522 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3940 | Indirect |
Footnotes
F1: Represents shares purchased through Employee Stock Purchase Plan.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.769 to $11.80, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.